[removed]Synergo system consists of two separate components,

First Page		Document Content
Date: 2008-07-29 09:38:30 Clinical research Pharmaceutical industry Pharmacology Aziridines Quinones Food and Drug Administration Bladder cancer Transitional cell carcinoma Clinical trial Medicine Oncology Pharmaceutical sciences		[removed]Synergo system consists of two separate components, Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 259,70 KB Share Document on Facebook

	In silico toxicology: Current usage and future directions Glenn J. Myatt () Leadscope, Inc. American College of Toxicology DocID: 1ovTC - View Document
	Electronic Supplementary Data Chitosan biohydrogel beads: A recyclable, biodegradable, heterogeneous catalyst for the regioselective synthesis of 5-aryl-2-oxazolidinones from carbon dioxide and aziridines at mild condit DocID: RwHU - View Document
$Aziridines / Quinones / Trabeculectomy / Mitomycin / Glaucoma / Photorefractive keratectomy / Bevacizumab / Fluorouracil / Stomach cancer / Medicine / Eye surgery / Blindness$	College of Pharmacy and Nutrition University of Saskatchewan Saskatoon SK S7N 5C9 www.medsask.usask.ca[removed]Saskatoon); [removed]SK) DocID: KIUb - View Document
	Microsoft Word - 2 AGENDA for Synergo[removed]jhb _2_.doc DocID: kGdT - View Document
	[removed]Synergo system consists of two separate components, DocID: kqag - View Document